Control of the Opening of mPTP by Ex Vivo Measurements on Permeabilized Muscle Fibers (COMMEF)

计划入组 40 人 · 首次发布于 2019 年 12 月 24 日

Revive IPTp study

计划入组 4,080 人

Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi

计划入组 602 人 · 首次发布于 2017 年 1 月 4 日

mPTP inhibitor (oral, Parkinson's disease)

mPTP inhibitor series (NRG Therapeutics)

mPTP inhibitor series (oral, amyotrophic lateral sclerosis)

NRG Therapeutics Raises $67 Million to Advance Novel Mitochondrial-Targeting Therapy for Parkinson's and ALS

Jupiter Neurosciences Receives FDA IND Clearance for JOTROL Phase 2a Trial in Parkinson's Disease

Jupiter Neurosciences Advances JOTROL into Phase 2a Parkinson's Trial Following FDA Clearance